GeneDx Holdings WGS Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's other accrued liabilities?
- GeneDx Holdings (WGS) reported other accrued liabilities of $35.95M in Q1 2026.
- How has GeneDx Holdings's other accrued liabilities changed year-over-year?
- GeneDx Holdings's other accrued liabilities increased by 46.4% year-over-year, from $24.56M to $35.95M.
- What is the long-term trend for GeneDx Holdings's other accrued liabilities?
- Over 4 years (2020 to 2025), GeneDx Holdings's other accrued liabilities has grown at a 13.6% compound annual growth rate (CAGR), from $28.14M to $46.86M.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.